{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:04:58Z","timestamp":1776492298650,"version":"3.51.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T00:00:00Z","timestamp":1516924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00213-018-4832-9","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T06:16:54Z","timestamp":1516947414000},"page":"1151-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice"],"prefix":"10.1007","volume":"235","author":[{"given":"Nina Z.","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Treven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rok","family":"Cerne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wakulchik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Schkeryantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Toufiqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanguan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Poe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,26]]},"reference":[{"issue":"2","key":"4832_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1134\/S0006297917020043","volume":"82","author":"TV Andreeva","year":"2017","unstructured":"Andreeva TV, Lukiw WJ, Rogaev EI (2017) Biological Basis for amyloidogenesis in Alzheimer\u2019s disease. Biochemistry (Mosc) 82(2):122\u2013139. \n                    https:\/\/doi.org\/10.1134\/S0006297917020043","journal-title":"Biochemistry (Mosc)"},{"issue":"1-3","key":"4832_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2006.02.055","volume":"548","author":"JR Atack","year":"2006","unstructured":"Atack JR, Bayley PJ, Fletcher SR, McKernan RM, Wafford KA, Dawson GR (2006a) The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated. Eur J Pharmacol 548(1-3):77\u201382. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2006.02.055","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"4832_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","volume":"51","author":"JR Atack","year":"2006","unstructured":"Atack JR, Bayley PJ, Seabrook GR, Wafford KA, McKernan RM, Dawson GR (2006b) L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. Neuropharmacology 51(6):1023\u20131029. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2006.04.018","journal-title":"Neuropharmacology"},{"issue":"2","key":"4832_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1124\/jpet.109.157636","volume":"331","author":"JR Atack","year":"2009","unstructured":"Atack JR, Maubach KA, Wafford KA, O'Connor D, Rodrigues AD, Evans DC, Tattersall FD, Chambers MS, MacLeod AM, Eng WS, Ryan C, Hostetler E, Sanabria SM, Gibson RE, Krause S, Burns HD, Hargreaves RJ, Agrawal NGB, McKernan RM, Murphy MG, Gingrich K, Dawson GR, Musson DG, Petty KJ (2009) In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist. J Pharmacol Exp Ther 331(2):470\u2013484. \n                    https:\/\/doi.org\/10.1124\/jpet.109.157636","journal-title":"J Pharmacol Exp Ther"},{"key":"4832_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0091-3057(01)00599-8","volume":"70","author":"F Bai","year":"2001","unstructured":"Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of \u201cbehavioral despair\u201d. Pharmacol Biochem Behav 70:187\u2013192","journal-title":"Pharmacol Biochem Behav"},{"key":"4832_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","volume":"202","author":"TM Ballard","year":"2009","unstructured":"Ballard TM, Knoflach F, Prinssen E, Borroni E, Vivian JA et al (2009) RO4938581, a novel cognitive enhancer acting at GABAA \u03b15 subunit-containing receptors. Psychopharmacology 202:207\u2013223","journal-title":"Psychopharmacology"},{"issue":"10","key":"4832_CR7","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/npp.2016.49","volume":"41","author":"LM Behlke","year":"2016","unstructured":"Behlke LM, Foster RA, Liu J, Benke D, Benham RS, Nathanson AJ, Yee BK, Zeilhofer HU, Engin E, Rudolph U (2016) A pharmacogenetic \u2018restriction-of-function\u2019 approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing gabaa receptors in mice. Neuropsychopharmacology 41(10):2492\u20132501. \n                    https:\/\/doi.org\/10.1038\/npp.2016.49","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"4832_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/ijnp\/pyx003","volume":"20","author":"FR Carreno","year":"2017","unstructured":"Carreno FR, Collins GT, Frazer A, Lodge DJ (2017) Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects. Int J Neuropsychopharmacol 20(6):504\u2013509. \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyx003","journal-title":"Int J Neuropsychopharmacol"},{"key":"4832_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/430248","volume":"2015","author":"T Clayton","year":"2015","unstructured":"Clayton T, Poe MM, Rallapalli S, Biawat P, Savi\u0107 MM, Rowlett JK, Gallos G, Emala CW, Kaczorowski CC, Stafford DC, Arnold LA, Cook JM (2015) A review of the updated pharmacophore for the alpha 5 GABA(a) benzodiazepine receptor model. Int J Med Chem 2015:1\u201354. \n                    https:\/\/doi.org\/10.1155\/2015\/430248","journal-title":"Int J Med Chem"},{"issue":"13","key":"4832_CR10","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","volume":"22","author":"N Collinson","year":"2002","unstructured":"Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, Smith A, Otu FM, Howell O, Atack JR, McKernan RM, Seabrook GR, Dawson GR, Whiting PJ, Rosahl TW (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 22(13):5572\u20135580","journal-title":"J Neurosci"},{"key":"4832_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238\u2013245","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"4832_CR12","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/npp.2015.112","volume":"40","author":"J Fischell","year":"2015","unstructured":"Fischell J, Van Dyke AM, Kvarta MD, LeGates TA, Thompson SM (2015) Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of alpha5-containing GABAA receptors. Neuropsychopharmacology 40(11):2499\u20132509. \n                    https:\/\/doi.org\/10.1038\/npp.2015.112","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"4832_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1124\/jpet.108.143362","volume":"329","author":"DR Gehlert","year":"2009","unstructured":"Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM (2009) Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression. J Pharmacol Exp Ther 329(2):429\u2013438. \n                    https:\/\/doi.org\/10.1124\/jpet.108.143362","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4832_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.neuroscience.2004.03.043","volume":"126","author":"M Haj\u00f3s","year":"2004","unstructured":"Haj\u00f3s M, Hoffmann WE, Orb\u00e1n G, Kiss T, Erdi P (2004) Modulation of septo-hippocampal theta activity by GABAA receptors: an experimental and computational approach. Neuroscience 126(3):599\u2013610. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2004.03.043","journal-title":"Neuroscience"},{"issue":"1","key":"4832_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02741459","volume":"18","author":"W Hevers","year":"1998","unstructured":"Hevers W, L\u00fcddens H (1998) The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 18(1):35\u201386. \n                    https:\/\/doi.org\/10.1007\/BF02741459","journal-title":"Mol Neurobiol"},{"issue":"10","key":"4832_CR16","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1111\/j.1532-5415.2011.03589.x","volume":"59","author":"TJ Hohman","year":"2011","unstructured":"Hohman TJ, Beason-Held LL, Resnick SM (2011) Cognitive complaints, depressive symptoms, and cognitive impairment: are they related? J Am Geriatr Soc 59(10):1908\u20131912. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03589.x","journal-title":"J Am Geriatr Soc"},{"issue":"5806","key":"4832_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/290514a0","volume":"290","author":"W Hunkeler","year":"1981","unstructured":"Hunkeler W, M\u00f6hler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290(5806):514\u2013516. \n                    https:\/\/doi.org\/10.1038\/290514a0","journal-title":"Nature"},{"key":"4832_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, Van Boxtel M et al (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s and Dementia 10:844\u2013852","journal-title":"Alzheimer\u2019s and Dementia"},{"issue":"3","key":"4832_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-150292","volume":"49","author":"P Jul","year":"2015","unstructured":"Jul P, Volbracht C, de Jong IE, Helboe L, Elvang AB, Pedersen JT (2015) Hyperactivity with agitative-like behavior in a mouse tauopathy model. J Alzheimers Dis 49(3):783\u2013795. \n                    https:\/\/doi.org\/10.3233\/JAD-150292","journal-title":"J Alzheimers Dis"},{"key":"4832_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pbb.2015.11.012","volume":"141","author":"AHFF Le\u00e3o","year":"2016","unstructured":"Le\u00e3o AHFF, Cabral A, Iz\u00eddio GS, Ribeiro AM, Silva RH (2016) Diazepam effects on aversive memory retrieval and extinction: role of anxiety levels. Pharmacol Biochem Behav 141:42\u201349. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2015.11.012","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"4832_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/acschemneuro.6b00447","volume":"8","author":"LA Lewter","year":"2017","unstructured":"Lewter LA, Fisher JL, Siemian JN, Methuku KR, Poe MM, Cook JM, Li JX (2017) Antinociceptive effects of a novel \u03b12\/\u03b13-subtype selective GABAA receptor positive allosteric modulator. ACS Chem Neurosci 8(6):1305\u20131312. \n                    https:\/\/doi.org\/10.1021\/acschemneuro.6b00447","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"4832_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1023\/A:1023648923447","volume":"23","author":"X Li","year":"2003","unstructured":"Li X, Witkin JM, Nead AB, Skolnick P (2003) Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol 23(3):419\u2013430. \n                    https:\/\/doi.org\/10.1023\/A:1023648923447","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"4832_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1124\/jpet.106.103143","volume":"319","author":"X Li","year":"2006","unstructured":"Li X, Need AB, Baez M, Witkin JM (2006) mGlu5 receptor antagonism is associated with antidepressant-like effects in mice. J Pharmacol Exp Ther 319(1):254\u2013259. \n                    https:\/\/doi.org\/10.1124\/jpet.106.103143","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"4832_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.2174\/1567205013666160502122933","volume":"13","author":"CS Liu","year":"2016","unstructured":"Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanct\u00f4t KL (2016) Pharmacological management of agitation and aggression in Alzheimer\u2019s disease: a review of current and novel treatments. Curr Alzheimer Res 13(10):1134\u20131144. \n                    https:\/\/doi.org\/10.2174\/1567205013666160502122933","journal-title":"Curr Alzheimer Res"},{"key":"4832_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-142508","volume":"47","author":"H Liu-Seifert","year":"2015","unstructured":"Liu-Seifert H, Siemers E, Price K, Han B, Selzler KJ, Henley D, Sundell K, Aisen P, Cummings J, Raskin J, Mohs R (2015) Alzheimer\u2019s disease neuroimaging initiative. cognitive impairment precedes and predicts functional impairment in mild Alzheimer\u2019s disease. J Alzheimers Dis 47:205\u2013214","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"4832_CR26","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1152\/jn.00597.2013","volume":"112","author":"BS Martin","year":"2014","unstructured":"Martin BS, Corbin JG, Huntsman MM (2014) Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala. J Neurophysiol 112(4):890\u2013902. \n                    https:\/\/doi.org\/10.1152\/jn.00597.2013","journal-title":"J Neurophysiol"},{"issue":"9","key":"4832_CR27","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","volume":"33","author":"C Mart\u00ednez-Cu\u00e9","year":"2013","unstructured":"Mart\u00ednez-Cu\u00e9 C, Mart\u00ednez P, Rueda N, Vidal R, Garc\u00eda S, Vidal V, Corrales A, Montero JA, Pazos \u00c1, Fl\u00f3rez J, Gasser R, Thomas AW, Honer M, Knoflach F, Trejo JL, Wettstein JG, Hern\u00e1ndez MC (2013) Reducing GABAA \u03b15 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome. J Neurosci 33(9):3953\u20133966. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1203-12.2013","journal-title":"J Neurosci"},{"issue":"1","key":"4832_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/10253890701200997","volume":"10","author":"K Matsumoto","year":"2007","unstructured":"Matsumoto K, Puia G, Dong E, Pinna G (2007) GABAA receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders. Stress 10(1):3\u201312. \n                    https:\/\/doi.org\/10.1080\/10253890701200997","journal-title":"Stress"},{"issue":"10","key":"4832_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jagp.2016.07.017","volume":"24","author":"AP Mendes-Silva","year":"2016","unstructured":"Mendes-Silva AP, Pereira KS, Tolentino-Araujo GT, Nicolau Ede S, Silva-Ferreira CM, Teixeira AL, Diniz BS (2016) Shared biologic pathways between Alzheimer disease and major depression: a systematic review of microRNA expression studies. Am J Geriatr Psychiatry 24(10):903\u2013912. \n                    https:\/\/doi.org\/10.1016\/j.jagp.2016.07.017","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"4832_CR30","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/jpet.108.138859","volume":"327","author":"NR Mirza","year":"2008","unstructured":"Mirza NR, Larsen JS, Mathiasen C, Jacobsen TA, Munro G, Erichsen HK, Nielsen AN, Troelsen KB, Nielsen EO, Ahring PK (2008) NS11394 [3\u2032-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy. J Pharmacol Exp Ther 327(3):954\u2013968. \n                    https:\/\/doi.org\/10.1124\/jpet.108.138859","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"4832_CR31","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1042\/BST0371328","volume":"37","author":"H M\u00f6hler","year":"2009","unstructured":"M\u00f6hler H (2009) Role of GABAA receptors in cognition. Biochem Soc Trans 37(6):1328\u20131333. \n                    https:\/\/doi.org\/10.1042\/BST0371328","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"4832_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/da.22584","volume":"34","author":"J Moraros","year":"2017","unstructured":"Moraros J, Nwankwo C, Patten SB, Mousseau DD (2017) The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: a systematic review and meta-analysis. Depress Anxiety 34(3):217\u2013226. \n                    https:\/\/doi.org\/10.1002\/da.22584","journal-title":"Depress Anxiety"},{"key":"4832_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/gps.4406","volume":"31","author":"RJ Mourao","year":"2016","unstructured":"Mourao RJ, Mansur G, Malloy-Diniz LF, Castro Costa E, Diniz BS (2016) Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis. Int J Geriatr Psychiatry 31:905\u2013911","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"4832_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0091-3057(89)90454-1","volume":"33","author":"H Nishimura","year":"1989","unstructured":"Nishimura H, Ida Y, Tsuda A, Tanaka M (1989) Opposite effects of diazepam and beta-CCE on immobility and straw-climbing behavior of rats in a modified forced-swim test. Pharmacol Biochem Behav 33(1):227\u2013231. \n                    https:\/\/doi.org\/10.1016\/0091-3057(89)90454-1","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"4832_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(a) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60(3):243\u2013260. \n                    https:\/\/doi.org\/10.1124\/pr.108.00505","journal-title":"Pharmacol Rev"},{"issue":"4","key":"4832_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF00498510","volume":"321","author":"P Polc","year":"1982","unstructured":"Polc P, Bonetti EP, Schaffner R, Haefely W (1982) A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, \u03b2-carbolines, and phenobarbitone. Naunyn Schmiedeberg's Arch Pharmacol 321(4):260\u2013264. \n                    https:\/\/doi.org\/10.1007\/BF00498510","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"3","key":"4832_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00213-008-1158-z","volume":"198","author":"P Popik","year":"2008","unstructured":"Popik P, Kos T, Sowa-Ku_cma M, Nowak G (2008) Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology 198(3):421\u2013430. \n                    https:\/\/doi.org\/10.1007\/s00213-008-1158-z","journal-title":"Psychopharmacology"},{"key":"4832_CR38","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"6","key":"4832_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/14656566.2017.1307340","volume":"18","author":"AP Porsteinsson","year":"2017","unstructured":"Porsteinsson AP, Antonsdottir IM (2017) An update on the advancements in the treatment of agitation in Alzheimer\u2019s disease. Expert Opin Pharmacother 18(6):611\u2013620. \n                    https:\/\/doi.org\/10.1080\/14656566.2017.1307340","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"4832_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1152\/jn.01199.2005","volume":"96","author":"GA Prenosil","year":"2006","unstructured":"Prenosil GA, Schneider Gasser EM, Rudolph U, Keist R, Fritschy JM, Vogt KE (2006) Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol 96(2):846\u2013857. \n                    https:\/\/doi.org\/10.1152\/jn.01199.2005","journal-title":"J Neurophysiol"},{"issue":"9-10","key":"4832_CR41","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0028-3908(96)00061-5","volume":"35","author":"K Quirk","year":"1996","unstructured":"Quirk K, Blurton P, Fletcher S, Leeson P, Tang F, Mellilo D, Ragan CI, McKernan RM (1996) [3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit. Neuropharmacology 35(9-10):1331\u20131335. \n                    https:\/\/doi.org\/10.1016\/S0028-3908(96)00061-5","journal-title":"Neuropharmacology"},{"issue":"46","key":"4832_CR42","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, Ashe KH (2005) Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25(46):10637\u201310647. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3279-05.2005","journal-title":"J Neurosci"},{"issue":"1","key":"4832_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","volume":"54","author":"U Rudolph","year":"2014","unstructured":"Rudolph U, M\u00f6hler H (2014) GABAA receptor subtypes: therapeutic potential in down syndrome, affective disorders, schizophrenia, and autism. Annu Rev Pharmacol Toxicol 54(1):483\u2013507. \n                    https:\/\/doi.org\/10.1146\/annurev-pharmtox-011613-135947","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4832_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.brainres.2008.02.020","volume":"1208","author":"MM Savi\u0107","year":"2008","unstructured":"Savi\u0107 MM, Clayton T, Furtm\u00fcller R, Gavrilovi\u0107 I, Samardzi\u0107 J, Savi\u0107 S, Huck S, Sieghart W, Cook JM (2008a) PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(a) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Res 1208:150\u2013159. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2008.02.020","journal-title":"Brain Res"},{"issue":"2","key":"4832_CR45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/sj.npp.1301403","volume":"33","author":"MM Savi\u0107","year":"2008","unstructured":"Savi\u0107 MM, Huang S, Furtm\u00fcller R, Clayton T, Huck S, Obradovi\u0107 DI, Ugresi\u0107 ND, Sieghart W, Bokonji\u0107 DR, Cook JM (2008b) Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists? Neuropsychopharmacology 33(2):332\u2013339. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1301403","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"4832_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7(3):280\u2013292. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","journal-title":"Alzheimers Dement"},{"issue":"3","key":"4832_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacologia 85(3):367\u2013370. \n                    https:\/\/doi.org\/10.1007\/BF00428203","journal-title":"Psychopharmacologia"},{"issue":"1-2","key":"4832_CR48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0006-8993(99)01152-X","volume":"822","author":"C Sur","year":"1999","unstructured":"Sur C, Fresu L, Howell O, McKernan RM, Atack JR (1999) Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain. Brain Res 822(1-2):265\u2013270. \n                    https:\/\/doi.org\/10.1016\/S0006-8993(99)01152-X","journal-title":"Brain Res"},{"issue":"7","key":"4832_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/gps.4704","volume":"32","author":"TM Terum","year":"2017","unstructured":"Terum TM, Andersen JR, Rongve A, Aarsland D, Svendsboe EJ, Testad I (2017) The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review. Int J Geriatr Psychiatry 32(7):703\u2013717. \n                    https:\/\/doi.org\/10.1002\/gps.4704","journal-title":"Int J Geriatr Psychiatry"},{"key":"4832_CR50","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/BF00212837","volume":"94","author":"MH Thi\u00e9bot","year":"1988","unstructured":"Thi\u00e9bot MH, Soubri\u00e9 P, Sanger D (1988) Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls. Psychopharmacology 94:452\u2013463","journal-title":"Psychopharmacology"},{"issue":"3","key":"4832_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1113\/jphysiol.2004.071191","volume":"559","author":"SK Towers","year":"2004","unstructured":"Towers SK, Gloveli T, Traub RD, Driver JE, Engel D, Fradley R, Rosahl TW, Maubach K, Buhl EH, Whittington MA (2004) Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro. J Physiol 559(3):721\u2013728. \n                    https:\/\/doi.org\/10.1113\/jphysiol.2004.071191","journal-title":"J Physiol"},{"issue":"1","key":"4832_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","volume":"185","author":"R Trullas","year":"1990","unstructured":"Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185(1):1\u201310. \n                    https:\/\/doi.org\/10.1016\/0014-2999(90)90204-J","journal-title":"Eur J Pharmacol"},{"key":"4832_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbr.2012.12.008","volume":"242","author":"A Jeugd Van der","year":"2013","unstructured":"Van der Jeugd A, Blum D, Raison S, Eddarkaoui S, Buee L, D'Hooge R (2013) Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia. Behav Brain Res 242:34\u201339. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2012.12.008","journal-title":"Behav Brain Res"},{"issue":"2","key":"4832_CR54","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bph.12151","volume":"169","author":"Z Varagic","year":"2013","unstructured":"Varagic Z, Wimmer L, Schn\u00fcrch M, Mihovilovic MD, Huang S, Rallapalli S, Cook JM, Mirheydari P, Ecker GF, Sieghart W, Ernst M (2013) Identification of novel positive allosteric modulators and null modulators at the GABAA receptor \u03b1+\u03b2- interface. Br J Pharmacol 169(2):371\u2013383. \n                    https:\/\/doi.org\/10.1111\/bph.12151","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4832_CR55","doi-asserted-by":"publisher","first-page":"0285","DOI":"10.1523\/ENEURO.0285-16.2017","volume":"4","author":"P Zanos","year":"2017","unstructured":"Zanos P, Nelson ME, Highland JN, Krimmel SR, Georgiou P, Gould TD, Thompson SM (2017) A Negative allosteric modulator for \u03b15 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice. eNeuro 4(1):0285\u201316.2017. \n                    https:\/\/doi.org\/10.1523\/ENEURO.0285-16.2017","journal-title":"eNeuro"},{"issue":"3","key":"4832_CR56","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1152\/jn.91203.2008","volume":"101","author":"ED Zarnowska","year":"2009","unstructured":"Zarnowska ED, Keist R, Rudolph U, Pearce RA (2009) GABAA receptor alpha5 subunits contribute to GABAA, slow synaptic inhibition in mouse hippocampus. J Neurophysiol 101(3):1179\u20131191. \n                    https:\/\/doi.org\/10.1152\/jn.91203.2008","journal-title":"J Neurophysiol"},{"key":"4832_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","volume":"190","author":"QF Zhao","year":"2016","unstructured":"Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L, Xu W, Li JQ, Wang J, Lai TJ, Yu JT (2016) The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: Systematic review and meta-analysis. J Affect Disord 190:264\u2013271. \n                    https:\/\/doi.org\/10.1016\/j.jad.2015.09.069","journal-title":"J Affect Disord"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-4832-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T00:18:56Z","timestamp":1548461936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-4832-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,26]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4832"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-4832-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,26]]},"assertion":[{"value":"11 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}